“Game Changer”: Health Professionals’ Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management

BACKGROUND: We explored health professionals’ views on the utility of circulating tumor DNA (ctDNA) testing in hereditary cancer syndrome (HCS) management. MATERIALS AND METHODS: A qualitative interpretive description study was conducted, using semi-structured interviews with professionals across Ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Shickh, Salma, Oldfield, Leslie E, Clausen, Marc, Mighton, Chloe, Sebastian, Agnes, Calvo, Alessia, Baxter, Nancy N, Dawson, Lesa, Penney, Lynette S, Foulkes, William, Basik, Mark, Sun, Sophie, Schrader, Kasmintan A, Regier, Dean A, Karsan, Aly, Pollett, Aaron, Pugh, Trevor J, Kim, Raymond H, Bombard, Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Health Outcomes and Economics of Cancer Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075003/
https://www.ncbi.nlm.nih.gov/pubmed/35385106
http://dx.doi.org/10.1093/oncolo/oyac039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075003/
https://www.ncbi.nlm.nih.gov/pubmed/35385106
http://dx.doi.org/10.1093/oncolo/oyac039

Ejemplares similares